XERIS BIOPHARMA HOLDINGS, INC.

Analyst Reco. Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Market Closed - Nasdaq Other stock markets 01:30:00 03/05/2024 am IST			5-day change	1st Jan Change
1.85 ^USD	+5.71%		+8.82%	-21.28%

28/03	Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	MT
18/03	Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	28/03	MT
Craig-Hallum Initiates Xeris Biopharma Holdings at Buy Rating With $4.50 Price Target	28/23/28	MT
SVB Securities Trims Xeris Biopharma Price Target to $5 From $6, Maintains Outperform Rating	27/23/27	MT
Jefferies Starts Xeris Biopharma Holdings at Buy With $4 Price Target	21/22/21	MT
Craig-Hallum Starts Xeris Biopharma Holdings at Buy With $6.50 Price Target	28/22/28	MT
Mizuho Securities Adjusts Xeris Biopharma Holdings' Price Target to $6 From $8, Keeps Buy Rating	16/22/16	MT
SVB Leerink Adjusts Xeris Biopharma Holdings Price Target to $6 From $8, Maintains Outperform Rating	16/22/16	MT
SVB Leerink Raises Price Target on Xeris Biopharma Holdings to $8 From $6, Maintains Outperform Rating	31/21/31	MT
HC Wainwright Raises Price Target on Xeris Biopharma Holdings to $5.40 From $4.25, Maintains Buy Rating	31/21/31	MT
SVB Leerink Starts Xeris Pharmaceuticals at Outperform With $6 Price Target	17/21/17	MT
HC Wainwright Starts Xeris Pharmaceuticals at Buy With $4 Price Target	29/21/29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer